Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06104969 · ClinicalTrials.gov registry record

DFC 004 Biomarkers for Active Diabetic Foot Ulcers

A clinical trial of Diabetes and Diabetic Foot Ulcer, sponsored by University of Michigan.

Recruiting
Registry status
5,000
Enrollment target
8
Study locations

NCT06104969 is a study of Diabetes and Diabetic Foot Ulcer that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 5,000 participants, above the 3,013-participant average among 338 other Diabetes trials with a reported enrollment target (66% higher). The trial reports 8 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06104969, a study of Diabetes and Diabetic Foot Ulcer, is actively recruiting participants, sponsored by University of Michigan.

RECRUITING
Registry status
5,000 participants
Enrollment target
8
Study locations

Study Summary

This study is a platform study designed to efficiently test multiple biomarkers to identify diabetic foot ulcers (DFUs) with a higher potential for healing versus not healing that ultimately could be applied at the point of care to drive personalized management decisions, and to better inform clinical trials of wound healing interventions

Study Locations (8)

California

  • University of Southern California - Los Angeles
  • University of California - San Francisco - San Francisco

Arizona

  • University of Arizona College of Medicine - Tucson

Georgia

  • Emory University School of Medicine - Atlanta

Massachusetts

  • Beth Israel Deaconess Medical Center - Boston

Michigan

  • University of Michigan - Ann Arbor

New York

  • Northwell Health - Lake Success

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 5,000 participants
Start Date 2023-06-15
Est. Completion 2028-06-15

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT06104969

The ClinicalTrials.gov registry entry for NCT06104969 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 3,013-participant average among 338 other Diabetes trials with a reported enrollment target (66% higher). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Diabetes appearing as the primary indexed condition, and to 0 interventions.

NCT06104969 reports 8 study locations spanning 7 distinct geographic areas - top geographies include California, Arizona, Georgia.

Frequently Asked Questions

What is clinical trial NCT06104969 about?

NCT06104969 is a clinical study titled "DFC 004 Biomarkers for Active Diabetic Foot Ulcers". This study is a platform study designed to efficiently test multiple biomarkers to identify diabetic foot ulcers (DFUs) with a higher potential for healing versus not healing that ultimately could be applied at the point of care to drive personalized management decisions, and to better inform clinic...

What is the current status of trial NCT06104969?

This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2023-06-15. Estimated completion is 2028-06-15.

What conditions does trial NCT06104969 study?

This clinical trial studies the following conditions: Diabetes, Diabetic Foot Ulcer, Diabetic Foot.

Who is sponsoring clinical trial NCT06104969?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06104969 being conducted?

This trial has 8 study locations across Arizona, California, Georgia, Massachusetts, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.